COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Curie Therapeutics is a fully integrated biotechnology company developing precision radiopharmaceutical conjugates delivering alpha- and beta-emitting radionuclide payloads to targeted solid tumors, with in-house ligand R&D, radiochemistry and clinical development.